CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bioceres Sa is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bioceres Sa
Ocampo 210 bis, Predio CCT
Phone: +54 3414861100p:+54 3414861100 ROSARIO, 2000  Argentina Ticker: BIOXBIOX

On 3/15/2019, the Company filed a Registration Withdrawal Request of its Form F-1 (File No. 333-222455) with the SEC, initially filed with the Commission on January 8, 2018. The Company is seeking withdrawal of the Registration Statement because it does not intend to pursue the contemplated public offering of the securities covered by the Registration Statement.

Business Summary
Bioceres SA is an Argentina-based company engaged in the agricultural biotechnology sector. The Company's activities are divided into three business segments: Seed Biotechnology, Agro-Industrial Biotechnology, as well as Research and Development (R&D) Services. The Seed Biotechnology segment develops seed traits, germplasms and seed treatment technologies that increase crop productivity of a range of grains, such as soybean, alfalfa, wheat, maize and amaranth. The Agro-Industrial Biotechnology division focuses on the development of microbial fermentation solutions, as well as on production of enzymes, which are applied within industrial areas, such as farming, food processing and biodiesel production. The R&D Services segment includes provision of biotechnology capacities to third-parties. The Company's projects comprise Inmet, Trigall Genetics, Semya, Verdeca, as well as Bioceres Semillas, among others.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20176/30/2017YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board MarceloAdolfo Carrique 58 4/1/2017 4/1/2008
Chief Executive Officer, Director FedericoTrucco 40 12/1/2014 6/1/2011
Independent Vice Chairman of the Board AimarDimo 52 4/1/2017 4/1/2008
12 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 25,586,700 (As of 9/30/2017)
Stock Exchange: NYSE


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, May 23, 2019